JAMA Ophthalmology
JAMA Ophthalmology is a peer-reviewed ophthalmology and visual science journal published by the American Medical Association, issued monthly with the online edition refreshed each Thursday. It descends from an ophthalmological and otological title founded in 1869 and is among the longest continuously published specialist journals in its field.《JAMA眼科学》（JAMA Ophthalmology）是美国医学会出版的眼科学与视觉科学同行评审学术期刊，月刊，在线部分每周四更新。该刊源自 1869 年创刊的一份眼科与耳科刊物，是眼科学界连续出版时间最长的专业期刊之一。
Scope
{本刊的取稿立场是「以改变眼科与视觉科学实践为尺度」，即要求研究须对眼科疾病的诊断、治疗或预防产生直接影响，并同时兼顾视觉科学的基础研究。刊物自述要成为眼科各层级读者不可缺的知识来源，同时为视觉科学研究者提供首选发表渠道。收文覆盖的主要方向包括：}-
- Posterior segment and retina: age-related macular degeneration, diabetic retinopathy, retinal vascular disease and inherited retinal degeneration.眼底病与视网膜： 年龄相关性黄斑变性、糖尿病视网膜病变、视网膜血管性疾病与遗传性视网膜变性。
- Glaucoma and optic nerve: early recognition of glaucoma, intraocular pressure control, and assessment of structural and functional damage to the optic nerve.青光眼与视神经： 青光眼的早期识别、眼压控制、视神经结构与功能损害的评估。
- Cornea and anterior segment: corneal disease, refractive surgery, and the technique and outcome appraisal of cataract and anterior segment reconstruction.角膜与眼前段： 角膜疾病、屈光手术、白内障与眼前段重建手术的术式与结局评价。
- Strabismus and paediatric ophthalmology: screening and treatment of childhood refractive error, amblyopia and strabismus, and long-term follow-up of paediatric eye disease.斜弱视与小儿眼科： 儿童屈光不正、弱视与斜视的筛查与治疗，以及小儿眼病的长期随访。
- Visual science and methodology: mechanisms of visual function, validation of ophthalmic imaging and diagnostics, and the design and appraisal of ophthalmic clinical trials.视觉科学与方法学： 视功能机制、眼科影像与诊断方法验证，以及眼科临床试验设计与评价。
The American Medical Association levies no author fees, and research articles become free to read online twelve months after publication, with access opened to institutions in developing countries through the World Health Organization's HINARI programme. The journal is indexed in the Science Citation Index Expanded and carries a 2025 impact factor of 9.2, ranking third among ophthalmology titles.美国医学会对本刊不设作者费用，研究论文发表十二个月后自动转为免费在线阅读，并通过世界卫生组织的 HINARI 计划向发展中国家机构开放。该刊被科学引文索引扩展版收录，2025 年影响因子 9.2，为眼科类期刊中排名第三者。
History
- Founding (1869): the journal was founded in New York as the Archives of Ophthalmology and Otology, with a simultaneous German-language edition published in Karlsruhe. The founding editors were Hermann Knapp, who practised both ophthalmology and otology in New York, and the otologist Salomon Moos of Heidelberg.创刊（1869年）： 本刊创刊于纽约，创刊刊名为《眼科与耳科学文献》，同期另有德文版在德国卡尔斯鲁厄出版；创刊编辑为在纽约执业的赫尔曼·克纳普与在海德堡执业的耳科学家萨洛蒙·莫斯。[1]
- Title succession (1869–2013): the Archives of Ophthalmology and Otology ran from 1869 to 1928, followed by the Archives of Ophthalmology from 1929 to 1950 and again from 1960 to 2012, with a society abbreviation prefix from 1950 to 1960, and the present name has been used since 2013.刊名沿革（1869–2013）： 1869–1928 年为《眼科与耳科学文献》，1929–1950 年与 1960–2012 年为《眼科学文献》，1950–1960 年带学会缩写前缀，2013 年起改用现名。[2]
- Joining the AMA (1929): the journal has been published by the American Medical Association since 1929, and by 2019 the society described it as marking 150 years of continuous publication, making it one of the longest-running titles in the family.加入美国医学会（1929年）： 该刊自 1929 年起由美国医学会出版，至 2019 年官方称其连续出版已达一百五十年，是学会期刊体系内历史最长的刊物之一。[3]
- Publication format: the journal is monthly, with twelve print and online issues a year and all articles appearing online first. The online edition is refreshed every Thursday, so a monthly print rhythm runs in parallel with a weekly online one.出版形态： 本刊为月刊，每年十二期印刷与在线并行，文章一律先在线发表；官方同时在线每周四更新，即纸质月刊与每周在线更新两套节奏并存。[3]
- Official acceptance rate: the publisher states an acceptance rate of 11 per cent, with a median of 3 days to first decision and 36 days to a decision with review. The former includes editorial screening and is pulled down heavily by manuscripts rejected without external review.官方录用率： 出版方官方公布本刊录用率为 11%，投稿至首次决定中位 3 天、经评审后 36 天；前者含编辑部初筛，这一极短数字主要由未经外审即退稿的稿件拉低。[3]
- Metric trend: the impact factor rose from 8.253 in 2021 to 9.2 in 2025, holding third place among ophthalmology titles. A third-party record of 10.5 for 2025 differs in source from the official figure of 9.2, and the official page should govern.指标走势： 影响因子自 2021 年的 8.253 升至 2025 年的 9.2，在眼科类期刊中稳居前三；第三方记录的 2025 年值 10.5 与官方页的 9.2 口径不同，宜以官方页为准。[3]
- Reach: the journal records more than six million article views and downloads a year, about 73 per cent of submissions coming from outside the United States, and a social media following of over 51,000. Among ophthalmology titles it accounted for 38 of the fifty highest-cited papers.传播规模： 该刊年论文浏览与下载量逾六百万次，国际作者比例约七成三，社交媒体关注者逾五万一；在眼科类期刊中，其最高被引论文占据前五十篇中的三十八篇。[3]
Editors
The journal operates under a single editor who heads the editorial office within the American Medical Association's journal family, with manuscripts submitted through the society's unified author system. The society publishes no editorial process detail beyond the acceptance rate and decision times, and the composition of the editorial office is taken from the masthead.本刊实行主编负责制，主编在美国医学会期刊体系内主持编辑部，稿件经学会统一的作者系统投递。官方不公布除录用率与决定时长之外的编辑流程细节，编辑部构成以刊头署名为准。
- Neil M. Bressler (current editor): professor at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine, his name and institution recorded in the editorial information block of the official author page.尼尔·布雷斯勒（现任主编）： 约翰斯·霍普金斯大学医学院威尔默眼科研究所教授，其姓名与机构在官方作者页的编者信息栏中载明。[3]
- Founding editors: the founding editors were Hermann Knapp of New York and the otologist Salomon Moos of Heidelberg, between them representing the ophthalmological and otological strands of the editorial tradition.创刊编辑： 创刊编辑为在纽约执业的赫尔曼·克纳普与在海德堡执业的耳科学家萨洛蒙·莫斯，两人分别代表眼科与耳科两个方向的编辑传统。[1]
- Frequency and editorial structure: the journal runs a monthly print schedule alongside weekly online updates, with the editorial office working inside the society's journal system so that its process and submission platform match the association's other specialty titles.刊期与编辑架构： 月刊编排与每周在线更新并存，编辑部在学会期刊体系内运作，编辑流程与投稿系统与其他美国医学会专科刊物一致。[3]
- Acceptance and speed: the official 11 per cent acceptance rate and the three-day median to first decision are the principal published evidence for understanding the journal's selection threshold. The two are measured differently, the first being an overall acceptance proportion and the second including editorial screening.录用与时效： 官方公布的 11% 录用率与 3 天首次决定中位数，是理解该刊取稿门槛的主要公开依据；两者口径不同，前者为总体录用比例，后者含编辑部初筛。[3]
- Standing in the field: one of the longest continuously published ophthalmology journals, its clinical research is cited directly in ophthalmic guidelines, and it accounted for 38 of the fifty highest-cited ophthalmology papers of 2025.学科地位： 该刊是眼科学界连续出版时间最长的刊物之一，其临床研究常被眼科指南直接引用，在 2025 年眼科类高被引论文中占据前五十篇的三十八篇。[3]